欧洲微创青光眼手术 (MIGS) 设备市场 – 行业趋势和 2030 年预测

请求目录 请求目录 与分析师交谈 与分析师交谈 立即购买 立即购买 购买前请咨询 提前咨询 免费样本报告 免费样本报告

欧洲微创青光眼手术 (MIGS) 设备市场 – 行业趋势和 2030 年预测

  • Medical Devices
  • Published Report
  • Sep 2023
  • Europe
  • 350 页面
  • 桌子數: 279
  • 图号: 39

Europe Micro Invasive Glaucoma Surgery Migs Devices Market

市场规模(十亿美元)

CAGR :  % Diagram

Diagram Forecast Period
2024 –2030
Diagram Market Size (Base Year)
USD MILLION
Diagram Market Size (Forecast Year)
USD 1,738.15
Diagram CAGR
%
Diagram Major Markets Players
  • Dummy1
  • Dummy2
  • Dummy3
  • Dummy4
  • Dummy5

欧洲微创青光眼手术 (MIGS) 设备市场,按产品类型(MIGS 分流器、MIGS 支架、小梁切除器、Kahook 双刀片、管分流器、微型植入物、微型导管等)、目标(小梁网、脉络膜上腔、结膜下滤过、减少房水产生等)、手术类型(合并白内障的青光眼、独立青光眼)、青光眼类型(开角型青光眼、急性闭角型青光眼、正常眼压性青光眼、继发性青光眼、色素性青光眼和先天性青光眼)、最终用户(医院门诊部 (HOPD)、眼科诊所、门诊手术中心(ASCS) 等)、分销渠道(直接招标、零售销售等)- 行业趋势和预测到 2030 年。

欧洲微创青光眼手术 (MIGS) 设备市场

欧洲微创青光眼手术 (MIGS) 设备市场分析与洞察

微创青光眼手术 (MIGS) 用于治疗开角型青光眼。最初,为了治疗开角型青光眼,医生会使用药物减少房水产生或增加房水流出。对于轻度至中度的开角型青光眼,传统上会进行药物和激光治疗。随着微创青光眼手术 (MIGS) 的出现,对于那些不适合进行传统手术的患者,医生们有了新的选择。老年人口的增加和政府预防失明的举措的增加预计将推动市场的发展。从青光眼药物到微创青光眼手术的快速转变可能会为 MIGS 设备制造商创造机会。

欧洲微创青光眼手术 (MIGS) 设备市场欧洲微创青光眼手术 (MIGS) 设备市场

Data Bridge Market Research 分析,欧洲微创青光眼手术 (MIGS) 设备市场预计到 2030 年将达到 17.3815 亿美元,预测期内 2023-2030 年的复合年增长率为 29.7%。由于对微创手术设备的需求不断增长,MIGS 分流器占据了市场上最大的产品类型细分市场。

报告指标

细节

预测期

2023 至 2030 年

基准年

2022

历史岁月

2021 (可定制为 2015-2020)

定量单位

收入(百万美元)、销量(单位)、定价(美元)

涵盖的领域

产品类型(MIGS 分流器、MIGS 支架、小梁切除器、Kahook 双刀片、管分流器、微型植入物、微型导管等)、目标(小梁网、脉络膜上腔、结膜下滤过、减少房水产生等)、手术类型(合并白内障的青光眼、独立性青光眼)、青光眼类型(开角型青光眼、急性闭角型青光眼、正常眼压性青光眼、继发性青光眼、色素性青光眼和先天性青光眼)、最终用户(医院门诊部 (HOPD)、眼科诊所、门诊手术中心 (ASCS) 等)、分销渠道(直接招标、零售等)

覆盖国家

德国、英国、法国、意大利、俄罗斯、西班牙、土耳其、瑞士、荷兰、比利时、丹麦、波兰、瑞典、挪威、芬兰和欧洲其他国家

涵盖的市场参与者

Glaukos corporation、AbbVie Inc.、Alcon、Johnson & Johnson Vision Care Inc.、Sight sciences, Inc.、Santen Pharmaceutical Co., Ltd、iSTAR Medical、BVI、Nova Eye Medical、Lumenis Be Ltd、Inami & Co., Ltd、Oertli Instrumente AG、Lumibird

欧洲微创青光眼手术 (MIGS) 设备市场定义

MIGS 代表微创青光眼手术,有助于治疗青光眼。这是治疗轻度至中度青光眼的突破性技术。它是之前药物治疗的替代品,还可以预防传统手术的并发症。这些手术用于降低眼内压,避免损伤视神经。与传统手术相比,这些手术更安全,恢复时间非常快。植入的各种 MIGS 设备包括分流器和支架,用于降低眼压。

眼部疾病发病率的不断上升、微创青光眼手术需求的不断增加、市场参与者数量的不断增加以及新产品的推出也推动了欧洲微创手术设备市场(MIGS)的增长。

欧洲微创青光眼手术 (MIGS) 设备市场动态

本节旨在了解市场驱动因素、优势、机遇、限制和挑战。下面将详细讨论所有这些内容:

驱动程序

  • 微创手术越来越受欢迎

青光眼是第二大常见失明原因。据世界卫生组织统计,有 450 万人因青光眼失明。治疗青光眼的唯一有效方法是降低眼压,以免损伤视神经。以前,治疗青光眼只有三种方法:药物治疗、激光治疗,以及在严重情况下的切口手术。药物治疗有一些缺点,如患者依从性和眼毒性。此外,这些药物价格昂贵,只有发展中国家的一些人才能使用。然而,激光疗法是非侵入性的。它们会随着时间的推移而失去效果。切口手术是降低眼压最有效的治疗方法。然而,它们可能会因疤痕、因滤泡相关的异物感导致的生活质量下降、诱发散光和继发性白内障而失败。

MIGS 提供更安全、侵入性更小的降低眼压的方法。此外,它们还减少了对药物的依赖。与切口手术相比,它们的恢复时间更快,效果也更好。因此,外科医生和患者越来越多地采用这些微创手术。因此,微创手术的日益普及有望推动市场增长。

  • 青光眼发病率上升

不可逆性全盲的主要原因是青光眼。青光眼是一组眼部疾病,初期症状很少或没有症状,但随后会导致视神经受损,从而导致视力丧失或失明。青光眼的患病率一直在增加。

提高生活质量有助于减轻青光眼的负担,因为青光眼有几个严重的风险因素。有必要转向革命性的技术,如微创青光眼手术,以在早期阶段克服它。因此,这创造了对 MIGS 设备的需求;因此,青光眼发病率的上升预计将成为市场驱动力。

欧洲微创青光眼手术 (MIGS) 设备市场

机会

  • 技术先进产品介绍

青光眼是一种严重的眼部疾病,如果不加以控制,会导致视力丧失。它通常不会导致失明,因为它可以通过现代治疗和许多防止进一步损害的选择来控制。随着科学的发展,青光眼的治疗发生了革命性的变化。随着微创青光眼手术的出现,医学发生了范式转变,因为它可以帮助早期治疗青光眼,避免对小梁切除术等过滤手术的依赖。这也克服了与这些切口手术相关的风险。使用 MIGS 治疗青光眼有各种进展。

这些新技术更安全,而且效果一般。因此,越来越多的患者和外科医生采用这些技术。这为制造商创造了生产技术更先进的设备的机会。因此,推出技术先进的产品可能成为市场的一个机会。

限制/挑战

  • 报销不足的情况

青光眼会危及视力;许多人每天都会因这种疾病而失明。轻度至中度青光眼患者通常接受药物治疗,而手术治疗仅限于重度青光眼患者。然而,随着 MIGS 设备的引入,青光眼治疗发生了范式转变。在早期进行微创青光眼手术可以避免晚期青光眼损伤。

外科医生不喜欢使用 MIGS 设备,因为报销额太低。当人们得不到报酬时,他们就会停止使用,最终导致其停止生产。尽管 MIGS 设备正在彻底改变青光眼的治疗,但保险公司对这些设备的批准和支付被视为一个障碍。因此,较低的报销额度预计将被视为市场的一个制约因素。

  • 缺乏具备足够知识的熟练专业人员

眼内手术是一项非常复杂的任务,因为手术必须在靠近易受影响结构的小空间内进行,任何失误都可能导致永久性视力丧失。这使得熟练的专业人员在场成为手术的必要条件。执行 MIGS 需要更高的技能水平,因为它涉及治疗、在眼睛内更小、更敏感的空间内工作,以及学习一种新的本体感受技能,即术中手术前房角镜观察角度。尽管非常需要熟练的专业人员在场,但发展中国家严重缺乏训练有素的外科医生。

此外,全球范围内都存在眼科手术专业人员短缺的问题,这使其成为治疗青光眼的一个严重问题。由于外科医生数量稀少,手术数量不足;因此,这被视为一个障碍。因此,市场对拥有足够知识的熟练专业人员的依赖程度很高,这可能会给市场带来挑战。

近期发展

  • 2022 年 2 月,参天将为医疗保健专业人员 (HCP) 推出一个创新的交互式医学教育平台。它让眼科医生能够按照自己的节奏获得高质量的个性化学习。这将有助于提高医疗保健专业人员的意识,并为公司带来更好的治疗和发展

欧洲微创青光眼手术 (MIGS) 设备市场范围

欧洲微创青光眼手术 (MIGS) 设备市场根据产品类型、目标、手术类型、青光眼类型、最终用户和分销渠道分为六个细分市场。细分市场之间的增长有助于您分析利基增长领域和进入市场的策略,并确定您的核心应用领域和目标市场的差异。

产品类型

  • 米格斯支架
  • 米格分流器
  • 小梁切除术
  • Kahook 双刃刀
  • 管分流器
  • 微型植入物
  • 微导管
  • 其他的

根据产品类型,欧洲微创青光眼手术 (MIGS) 设备市场分为 MIGS 分流器、MIGS 支架、小梁切除器、kahook 双刀片、管分流器、微型植入物、微型导管等。

目标

  • 小梁网
  • 脉络膜上腔
  • 结膜下滤过
  • 减少水产产量
  • 其他的

根据目标,欧洲微创青光眼手术(migs)设备市场细分为小梁网、脉络膜上腔、结膜下滤过、减少房水产生和其他。

手术类型

  • 青光眼并发白内障
  • 独立性青光眼

根据手术类型,欧洲微创青光眼手术 (MIGS) 设备市场分为与白内障相关的青光眼和独立青光眼。

青光眼类型

  • 开角型青光眼
  • 急性闭角型青光眼
  • 正常眼压性青光眼
  • 继发性青光眼
  • 色素性青光眼
  • 先天性青光眼

根据青光眼的类型,欧洲微创青光眼手术(migs)设备市场分为开角型青光眼、急性闭角型青光眼、正常眼压性青光眼、继发性青光眼、色素性青光眼和先天性青光眼。

最终用户

  • 医院门诊部(HOPD)
  • 眼科诊所
  • 门诊手术中心 (ASCS)
  • 其他的

根据最终用户,欧洲微创青光眼手术 (MIGS) 设备市场分为医院门诊部 (HOPD)、眼科诊所、门诊手术中心 (ASCS) 和其他。

分销渠道

  • 直接招标
  • 零售销售
  • 其他的

根据分销渠道,欧洲微创青光眼手术(MIGS)设备市场分为直接招标和零售。

欧洲微创青光眼手术 (MIGS) 设备市场

欧洲微创青光眼手术 (MIGS) 设备市场区域分析/见解

欧洲微创青光眼手术 (MIGS) 设备市场按产品类型、目标、手术类型、青光眼类型、最终用户和分销渠道分为六个部分。

本市场报告涵盖的国家包括德国、英国、法国、意大利、俄罗斯、西班牙、土耳其、瑞士、荷兰、比利时、丹麦、波兰、瑞典、挪威、芬兰和欧洲其他国家。

由于人口中青光眼或其他相关疾病的患病率上升,德国占据主导地位。

报告的国家部分还提供了影响单个市场因素和国内市场监管变化,这些因素和变化会影响市场的当前和未来趋势。新销售、替代销售、国家人口统计、监管法案和进出口关税等数据点是用于预测单个国家市场情景的一些主要指标。此外,在对国家数据进行预测分析时,还考虑了区域品牌的存在和可用性以及它们因来自本地和国内品牌的激烈或稀少竞争而面临的挑战,以及销售渠道的影响。

竞争格局和欧洲微创青光眼手术 (MIGS) 设备市场份额分析

欧洲微创青光眼手术 (MIGS) 设备市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、收入、市场潜力、研发投资、新市场计划、生产基地和设施、公司优势和劣势、产品发布、产品批准、产品宽度和广度、应用优势、技术生命线曲线。以上提供的数据点仅与公司对欧洲微创青光眼手术 (MIGS) 设备市场的关注有关。

欧洲微创青光眼手术 (MIGS) 设备市场的一些主要参与者包括 Glaukos corporation、AbbVie Inc.、Alcon、Johnson & Johnson Vision Care Inc.、Sight sciences, Inc.、Santen Pharmaceutical Co., Ltd、iSTAR Medical、BVI、Nova Eye Medical、Lumenis Be Ltd、Inami & Co., Ltd、Oertli Instrumente AG、Lumibird 等。


SKU-

Get online access to the report on the World's First Market Intelligence Cloud

  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

目录

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET

1.4 LIMITATIONS

1.5 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 CURRENCY AND PRICING

2.5 DBMR TRIPOD DATA VALIDATION MODEL

2.6 MULTIVARIATE MODELLING

2.7 PRODUCTS LIFELINE CURVE

2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.9 DBMR MARKET POSITION GRID

2.1 MARKET APPLICATION COVERAGE GRID

2.11 VENDOR SHARE ANALYSIS

2.12 SECONDARY SOURCES

2.13 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PRIMIUM INSIGHT

4.1 PESTEL

4.2 PORTER

5 VALUE CHAIN ANALYSIS

6 INDUSTRY INSIGHTS

6.1 MICRO AND MACROECONOMIC FACTORS

6.2 PENETRATION AND GROWTH PROSPECT MAPPING

6.3 KEY PRICING STRATEGIES

7 COST ANALYSIS BREAKDOWN

8 TECHNOLOGY ROADMAP

9 REIMBURSEMENT FRAMEWORK

10 INNOVATION TRACKER AND STRATEGIC ANALYSIS

11 REGULATION

12 MARKET OVERVIEW

12.1 DRIVERS

12.1.1 INCREASE IN THE GERIATRIC POPULATION

12.1.2 RISE IN INCIDENCE OF GLAUCOMA

12.1.3 GROWTH IN THE POPULARITY OF MINIMALLY INVASIVE SURGERY

12.2 RESTRAINTS

12.2.1 INADEQUATE REIMBURSEMENT SCENARIO

12.2.2 STRINGENT REGULATIONS FOR MIGS DEVICES

12.3 OPPORTUNITIES

12.3.1 RAPID TRANSITION FROM GLAUCOMA MEDICATION TO MINIMALLY INVASIVE GLAUCOMA SURGERIES

12.3.2 INTRODUCTION OF TECHNOLOGICAL ADVANCED PRODUCT

12.4 CHALLENGES

12.4.1 LACK OF SKILLED PROFESSIONALS WITH ADEQUATE KNOWLEDGE

12.4.2 RISKS ASSOCIATED WITH MICRO INVASIVE GLAUCOMA SURGERY

13 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE

13.1 OVERVIEW

13.2 MIGS STENTS

13.3 MIGS SHUNTS

13.4 TRABECTOME

13.5 KAHOOK DUAL BLADE

13.6 TUBE SHUNT

13.7 MICRO IMPLANTS

13.8 MICRO CATHETERS

13.9 OTHERS

14 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET

14.1 OVERVIEW

14.2 TRABECULAR MESHWORK

14.3 REDUCING AQUEOUS PRODUCTION

14.4 SUPRACHOROIDAL SPACE

14.5 SUBCONJUNCTIVAL FILTRATION

14.6 OTHERS

15 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE

15.1 OVERVIEW

15.2 GLAUCOMA IN CONJUNCTION WITH CATARACT

15.3 STAND-ALONE GLAUCOMA

16 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY GLAUCOMA TYPE

16.1 OVERVIEW

16.2 OPEN ANGLE GLAUCOMA

16.3 ACUTE ANGLE GLAUCOMA

16.4 NORMAL TENSION GLAUCOMA

16.5 SECONDARY GLAUCOMA

16.6 PIGMENTARY GLAUCOMA

16.7 CONGENITAL GLAUCOMA

17 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER

17.1 OVERVIEW

17.2 HOSPITAL OUTPATIENT DEPARTMENT (HOPD)

17.3 OPHTHALMOLOGY CLINICS

17.4 AMBULATORY SURGERY CENTERS (ASCS)

17.5 OTHERS

18 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL

18.1 OVERVIEW

18.2 DIRECT TENDER

18.3 RETAIL SALES

18.4 OTHERS

19 EUROPE

19.1 GERMANY

19.2 U.K.

19.3 FRANCE

19.4 ITALY

19.5 RUSSIA

19.6 SPAIN

19.7 TURKEY

19.8 SWITZERLAND

19.9 NETHERLANDS

19.1 BELGIUM

19.11 DENMARK

19.12 POLAND

19.13 SWEDEN

19.14 NORWAY

19.15 FINLAND

19.16 REST OF EUROPE

20 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: COMPANY LANDSCAPE

20.1 COMPANY SHARE ANALYSIS: EUROPE

21 SWOT ANALYSIS

22 QUESTIONNAIRE

23 RELATED REPORTS

表格列表

TABLE 1 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 2 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2021-2030 (USD MILLION)

TABLE 3 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2021-2030 (USD MILLION)

TABLE 4 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 5 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 6 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY COUNTRY, 2021-2030 (USD MILLION)

TABLE 7 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 8 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)

TABLE 9 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)

TABLE 10 EUROPE MIGS STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 11 EUROPE MIGS STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)

TABLE 12 EUROPE MIGS STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)

TABLE 13 EUROPE I-STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 14 EUROPE I-STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)

TABLE 15 EUROPE I-STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)

TABLE 16 EUROPE TRABECTOME IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 17 EUROPE TRABECTOME IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)

TABLE 18 EUROPE TRABECTOME IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)

TABLE 19 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2021-2030 (USD MILLION)

TABLE 20 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2021-2030 (USD MILLION)

TABLE 21 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY GLAUCOMA TYPE, 2021-2030 (USD MILLION)

TABLE 22 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 23 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 24 GERMANY MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 25 GERMANY MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)

TABLE 26 GERMANY MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)

TABLE 27 GERMANY MIGS STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 28 GERMANY MIGS STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)

TABLE 29 GERMANY MIGS STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)

TABLE 30 GERMANY I-STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 31 GERMANY I-STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)

TABLE 32 GERMANY I-STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)

TABLE 33 GERMANY TRABECTOME IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 34 GERMANY TRABECTOME IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)

TABLE 35 GERMANY TRABECTOME IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)

TABLE 36 GERMANY MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2021-2030 (USD MILLION)

TABLE 37 GERMANY MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2021-2030 (USD MILLION)

TABLE 38 GERMANY MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY GLAUCOMA TYPE, 2021-2030 (USD MILLION)

TABLE 39 GERMANY MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 40 GERMANY MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 41 U.K. MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 42 U.K. MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)

TABLE 43 U.K. MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)

TABLE 44 U.K. MIGS STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 45 U.K. MIGS STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)

TABLE 46 U.K. MIGS STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)

TABLE 47 U.K. I-STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 48 U.K. I-STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)

TABLE 49 U.K. I-STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)

TABLE 50 U.K. TRABECTOME IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 51 U.K. TRABECTOME IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)

TABLE 52 U.K. TRABECTOME IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)

TABLE 53 U.K. MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2021-2030 (USD MILLION)

TABLE 54 U.K. MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2021-2030 (USD MILLION)

TABLE 55 U.K. MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY GLAUCOMA TYPE, 2021-2030 (USD MILLION)

TABLE 56 U.K. MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 57 U.K. MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 58 FRANCE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 59 FRANCE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)

TABLE 60 FRANCE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)

TABLE 61 FRANCE MIGS STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 62 FRANCE MIGS STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)

TABLE 63 FRANCE MIGS STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)

TABLE 64 FRANCE I-STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 65 FRANCE I-STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)

TABLE 66 FRANCE I-STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)

TABLE 67 FRANCE TRABECTOME IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 68 FRANCE TRABECTOME IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)

TABLE 69 FRANCE TRABECTOME IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)

TABLE 70 FRANCE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2021-2030 (USD MILLION)

TABLE 71 FRANCE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2021-2030 (USD MILLION)

TABLE 72 FRANCE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY GLAUCOMA TYPE, 2021-2030 (USD MILLION)

TABLE 73 FRANCE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 74 FRANCE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 75 ITALY MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 76 ITALY MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)

TABLE 77 ITALY MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)

TABLE 78 ITALY MIGS STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 79 ITALY MIGS STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)

TABLE 80 ITALY MIGS STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)

TABLE 81 ITALY I-STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 82 ITALY I-STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)

TABLE 83 ITALY I-STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)

TABLE 84 ITALY TRABECTOME IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 85 ITALY TRABECTOME IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)

TABLE 86 ITALY TRABECTOME IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)

TABLE 87 ITALY MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2021-2030 (USD MILLION)

TABLE 88 ITALY MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2021-2030 (USD MILLION)

TABLE 89 ITALY MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY GLAUCOMA TYPE, 2021-2030 (USD MILLION)

TABLE 90 ITALY MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 91 ITALY MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 92 RUSSIA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 93 RUSSIA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)

TABLE 94 RUSSIA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)

TABLE 95 RUSSIA MIGS STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 96 RUSSIA MIGS STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)

TABLE 97 RUSSIA MIGS STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)

TABLE 98 RUSSIA I-STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 99 RUSSIA I-STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)

TABLE 100 RUSSIA I-STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)

TABLE 101 RUSSIA TRABECTOME IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 102 RUSSIA TRABECTOME IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)

TABLE 103 RUSSIA TRABECTOME IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)

TABLE 104 RUSSIA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2021-2030 (USD MILLION)

TABLE 105 RUSSIA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2021-2030 (USD MILLION)

TABLE 106 RUSSIA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY GLAUCOMA TYPE, 2021-2030 (USD MILLION)

TABLE 107 RUSSIA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 108 RUSSIA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 109 SPAIN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 110 SPAIN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)

TABLE 111 SPAIN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)

TABLE 112 SPAIN MIGS STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 113 SPAIN MIGS STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)

TABLE 114 SPAIN MIGS STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)

TABLE 115 SPAIN I-STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 116 SPAIN I-STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)

TABLE 117 SPAIN I-STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)

TABLE 118 SPAIN TRABECTOME IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 119 SPAIN TRABECTOME IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)

TABLE 120 SPAIN TRABECTOME IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)

TABLE 121 SPAIN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2021-2030 (USD MILLION)

TABLE 122 SPAIN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2021-2030 (USD MILLION)

TABLE 123 SPAIN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY GLAUCOMA TYPE, 2021-2030 (USD MILLION)

TABLE 124 SPAIN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 125 SPAIN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 126 TURKEY MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 127 TURKEY MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)

TABLE 128 TURKEY MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)

TABLE 129 TURKEY MIGS STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 130 TURKEY MIGS STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)

TABLE 131 TURKEY MIGS STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)

TABLE 132 TURKEY I-STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 133 TURKEY I-STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)

TABLE 134 TURKEY I-STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)

TABLE 135 TURKEY TRABECTOME IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 136 TURKEY TRABECTOME IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)

TABLE 137 TURKEY TRABECTOME IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)

TABLE 138 TURKEY MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2021-2030 (USD MILLION)

TABLE 139 TURKEY MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2021-2030 (USD MILLION)

TABLE 140 TURKEY MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY GLAUCOMA TYPE, 2021-2030 (USD MILLION)

TABLE 141 TURKEY MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 142 TURKEY MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 143 SWITZERLAND MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 144 SWITZERLAND MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)

TABLE 145 SWITZERLAND MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)

TABLE 146 SWITZERLAND MIGS STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 147 SWITZERLAND MIGS STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)

TABLE 148 SWITZERLAND MIGS STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)

TABLE 149 SWITZERLAND I-STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 150 SWITZERLAND I-STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)

TABLE 151 SWITZERLAND I-STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)

TABLE 152 SWITZERLAND TRABECTOME IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 153 SWITZERLAND TRABECTOME IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)

TABLE 154 SWITZERLAND TRABECTOME IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)

TABLE 155 SWITZERLAND MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2021-2030 (USD MILLION)

TABLE 156 SWITZERLAND MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2021-2030 (USD MILLION)

TABLE 157 SWITZERLAND MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY GLAUCOMA TYPE, 2021-2030 (USD MILLION)

TABLE 158 SWITZERLAND MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 159 SWITZERLAND MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 160 NETHERLANDS MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 161 NETHERLANDS MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)

TABLE 162 NETHERLANDS MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)

TABLE 163 NETHERLANDS MIGS STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 164 NETHERLANDS MIGS STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)

TABLE 165 NETHERLANDS MIGS STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)

TABLE 166 NETHERLANDS I-STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 167 NETHERLANDS I-STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)

TABLE 168 NETHERLANDS I-STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)

TABLE 169 NETHERLANDS TRABECTOME IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 170 NETHERLANDS TRABECTOME IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)

TABLE 171 NETHERLANDS TRABECTOME IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)

TABLE 172 NETHERLANDS MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2021-2030 (USD MILLION)

TABLE 173 NETHERLANDS MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2021-2030 (USD MILLION)

TABLE 174 NETHERLANDS MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY GLAUCOMA TYPE, 2021-2030 (USD MILLION)

TABLE 175 NETHERLANDS MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 176 NETHERLANDS MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 177 BELGIUM MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 178 BELGIUM MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)

TABLE 179 BELGIUM MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)

TABLE 180 BELGIUM MIGS STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 181 BELGIUM MIGS STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)

TABLE 182 BELGIUM MIGS STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)

TABLE 183 BELGIUM I-STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 184 BELGIUM I-STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)

TABLE 185 BELGIUM I-STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)

TABLE 186 BELGIUM TRABECTOME IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 187 BELGIUM TRABECTOME IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)

TABLE 188 BELGIUM TRABECTOME IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)

TABLE 189 BELGIUM MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2021-2030 (USD MILLION)

TABLE 190 BELGIUM MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2021-2030 (USD MILLION)

TABLE 191 BELGIUM MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY GLAUCOMA TYPE, 2021-2030 (USD MILLION)

TABLE 192 BELGIUM MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 193 BELGIUM MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 194 DENMARK MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 195 DENMARK MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)

TABLE 196 DENMARK MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)

TABLE 197 DENMARK MIGS STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 198 DENMARK MIGS STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)

TABLE 199 DENMARK MIGS STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)

TABLE 200 DENMARK I-STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 201 DENMARK I-STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)

TABLE 202 DENMARK I-STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)

TABLE 203 DENMARK TRABECTOME IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 204 DENMARK TRABECTOME IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)

TABLE 205 DENMARK TRABECTOME IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)

TABLE 206 DENMARK MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2021-2030 (USD MILLION)

TABLE 207 DENMARK MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2021-2030 (USD MILLION)

TABLE 208 DENMARK MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY GLAUCOMA TYPE, 2021-2030 (USD MILLION)

TABLE 209 DENMARK MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 210 DENMARK MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 211 POLAND MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 212 POLAND MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)

TABLE 213 POLAND MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)

TABLE 214 POLAND MIGS STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 215 POLAND MIGS STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)

TABLE 216 POLAND MIGS STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)

TABLE 217 POLAND I-STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 218 POLAND I-STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)

TABLE 219 POLAND I-STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)

TABLE 220 POLAND TRABECTOME IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 221 POLAND TRABECTOME IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)

TABLE 222 POLAND TRABECTOME IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)

TABLE 223 POLAND MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2021-2030 (USD MILLION)

TABLE 224 POLAND MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2021-2030 (USD MILLION)

TABLE 225 POLAND MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY GLAUCOMA TYPE, 2021-2030 (USD MILLION)

TABLE 226 POLAND MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 227 POLAND MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 228 SWEDEN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 229 SWEDEN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)

TABLE 230 SWEDEN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)

TABLE 231 SWEDEN MIGS STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 232 SWEDEN MIGS STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)

TABLE 233 SWEDEN MIGS STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)

TABLE 234 SWEDEN I-STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 235 SWEDEN I-STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)

TABLE 236 SWEDEN I-STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)

TABLE 237 SWEDEN TRABECTOME IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 238 SWEDEN TRABECTOME IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)

TABLE 239 SWEDEN TRABECTOME IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)

TABLE 240 SWEDEN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2021-2030 (USD MILLION)

TABLE 241 SWEDEN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2021-2030 (USD MILLION)

TABLE 242 SWEDEN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY GLAUCOMA TYPE, 2021-2030 (USD MILLION)

TABLE 243 SWEDEN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 244 SWEDEN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 245 NORWAY MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 246 NORWAY MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)

TABLE 247 NORWAY MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)

TABLE 248 NORWAY MIGS STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 249 NORWAY MIGS STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)

TABLE 250 NORWAY MIGS STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)

TABLE 251 NORWAY I-STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 252 NORWAY I-STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)

TABLE 253 NORWAY I-STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)

TABLE 254 NORWAY TRABECTOME IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 255 NORWAY TRABECTOME IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)

TABLE 256 NORWAY TRABECTOME IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)

TABLE 257 NORWAY MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2021-2030 (USD MILLION)

TABLE 258 NORWAY MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2021-2030 (USD MILLION)

TABLE 259 NORWAY MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY GLAUCOMA TYPE, 2021-2030 (USD MILLION)

TABLE 260 NORWAY MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 261 NORWAY MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 262 FINLAND MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 263 FINLAND MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)

TABLE 264 FINLAND MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)

TABLE 265 FINLAND MIGS STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 266 FINLAND MIGS STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)

TABLE 267 FINLAND MIGS STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)

TABLE 268 FINLAND I-STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 269 FINLAND I-STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)

TABLE 270 FINLAND I-STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)

TABLE 271 FINLAND TRABECTOME IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 272 FINLAND TRABECTOME IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)

TABLE 273 FINLAND TRABECTOME IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)

TABLE 274 FINLAND MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2021-2030 (USD MILLION)

TABLE 275 FINLAND MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2021-2030 (USD MILLION)

TABLE 276 FINLAND MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY GLAUCOMA TYPE, 2021-2030 (USD MILLION)

TABLE 277 FINLAND MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 278 FINLAND MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 279 REST OF EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

图片列表

FIGURE 1 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: SEGMENTATION

FIGURE 2 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: DATA TRIANGULATION

FIGURE 3 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: DROC ANALYSIS

FIGURE 4 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: EUROPE VS COUNTRY MARKET ANALYSIS

FIGURE 5 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 7 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: DBMR MARKET POSITION GRID

FIGURE 8 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: MARKET END USER GRID

FIGURE 9 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: VENDOR SHARE ANALYSIS

FIGURE 10 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: SEGMENTATION

FIGURE 11 INCREASING GERIATRIC POPULATIONAND RISING PREVALENCE OF GLAUCOMA IS EXPECTED TO DRIVE THE EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET IN THE FORECAST PERIOD OF 2023 TO 2030

FIGURE 12 PRODUCT TYPE SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET IN 2023 TO 2030

FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET

FIGURE 14 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY PRODUCT TYPE, 2022

FIGURE 15 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY PRODUCT TYPE, 2023-2030 (USD MILLION)

FIGURE 16 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY PRODUCT TYPE, CAGR (2023-2030)

FIGURE 17 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY PRODUCT TYPE, LIFELINE CURVE

FIGURE 18 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY TARGET, 2022

FIGURE 19 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY TARGET, 2023- 2030 (USD MILLION)

FIGURE 20 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY TARGET, CAGR (2023- 2030)

FIGURE 21 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY TARGET, LIFELINE CURVE

FIGURE 22 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY SURGERY TYPE, 2022

FIGURE 23 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY SURGERY TYPE, 2023-2030 (USD MILLION)

FIGURE 24 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY SURGERY TYPE, CAGR (2023-2030)

FIGURE 25 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY SURGERY TYPE, LIFELINE CURVE

FIGURE 26 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY GLAUCOMA TYPE, 2022

FIGURE 27 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY GLAUCOMA TYPE, 2023-2030 (USD MILLION)

FIGURE 28 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY GLAUCOMA TYPE, CAGR (2023-2030)

FIGURE 29 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY GLAUCOMA TYPE, LIFELINE CURVE

FIGURE 30 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY END USER, 2022

FIGURE 31 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY END USER, 2023-2030 (USD MILLION)

FIGURE 32 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY END USER, CAGR (2023- 2030)

FIGURE 33 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY END USER, LIFELINE CURVE

FIGURE 34 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY DISTRIBUTION CHANNEL, 2022

FIGURE 35 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY DISTRIBUTION CHANNEL, 2023-2030 (USD MILLION)

FIGURE 36 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY DISTRIBUTION CHANNEL, CAGR (2023-2030)

FIGURE 37 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE

FIGURE 38 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: SNAPSHOT (2022)

FIGURE 39 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: COMPANY SHARE 2022 (%)

查看详细信息 Right Arrow

研究方法

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

可定制

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Frequently Asked Questions

Micro Invasive Glaucoma Surgery (MIGS) Devices Market will be worth USD 1,738.15 million by 2030.
Micro Invasive Glaucoma Surgery (MIGS) Devices Market growth rate is 29.7% during the forecast period.
Growth in Popularity of Minimally Invasive Surgery and Rise in Incidence of Glaucoma are the growth drivers of the Micro Invasive Glaucoma Surgery (MIGS) Devices Market.
Product type, target, surgery type, glaucoma type, end user, and distribution channel are the factors on which the Micro Invasive Glaucoma Surgery (MIGS) Devices Market research is based.
Santen is launching an innovative, interactive medical education platform for healthcare professionals (HCPs) and it gives ophthalmologists access to high-quality, personalized learning at their own pace are the latest developments in the Micro Invasive Glaucoma Surgery (MIGS) Devices Market.